Skip to main content
OpenTrials
Completed

NCT Number: NCT02362581

Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A

Comparison of prophylaxis and on-demand treatment in children with moderate to severe hemophilia A.

This study determines to compare the efficacy of prophylaxis and on-demand treatment in moderate to severe hemophilia A children in King Chulalongkorn Memorial Hospital, Bangkok, Thailand

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

pediatric Hemato-oncology department, King Chulalongkorn Memorial Hospital

Pratumwan, Bangkok, 10330, Thailand

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age between 6 months to 18 years
  • Diagnosis severe and moderate hemophilia A

Exclusion criteria

  • platelet < 100,000/mm3
  • No factor VIII inhibitor

Treatment and study plan

prophylaxis treatment, on demand treatment

Other

Other names: Hemofil M

Primary outcomes

  1. Number of bleeding episodes require treatment

    Time frame: one year

  2. number of school days lost

    Time frame: one year

  3. Number of admission days

    Time frame: one year

Secondary outcomes

  1. Joint scores

    Time frame: one year

  2. Quality of life score

    Time frame: one year

  3. Amount of Facter VIII concentration used

    Time frame: one year

Sponsors and collaborators

Lead sponsor

Chulalongkorn University

Other

Registry information

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Feb 13, 2015
Registry last updated
Feb 13, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.